Medius Klinik Nurtingen

Nürtingen 72622

0 studies enrolling now · 2 studies all time

What they study most

Colitis, Ulcerative, Crohn's Disease

Studies at this site

• A Study of Combination Therapy With Guselkumab and Golimumab in Participants With Moderately to Severely Active Ulcerative Colitis — Running, not enrolling
• A Study of Combination Therapy With Guselkumab and Golimumab in Participants With Moderately to Severely Active Crohn's Disease — Running, not enrolling